Active-ingredient Dossier
Desmopressin Acetate
Active-ingredient Dossier for Desmopressin Acetate (vasopressin analogue). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: DESMOMED
- Brand: DESMOPRESSIN ADVZ
- Brand: OCTOSTIM
- Brand: DESMOPRESSIN
- Therapeutic area: Endocrinology
- Therapeutic area: Haematology
What is
Desmopressin Acetate Desmopressin Acetate is a vasopressin analogue.
Australian brands containing
Desmopressin Acetate — DESMOMED — DESMOPRESSIN ADVZ — OCTOSTIM
Therapeutic areas
Desmopressin Acetate is registered in two therapeutic areas: Endocrinology, where three brands are registered, and Immunology, where one brand is registered.
Sponsor landscape
Three sponsors market Desmopressin Acetate in Australia: Medsurge Pharma, Boucher & Muir, and Ferring Pharmaceuticals.
PBS and regulatory activity
Two brands containing Desmopressin Acetate have PBS-listed items, with the latest PBS schedule date being 1 May 2026. The latest PBAC outcome was recorded on 1 November 2025.